Alzheimer's Flashcards

1
Q

name two pathologic hallmarks of AD in the brain

A

neurofibrillary tangles

neuritic plaques

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

disruption of pathways by plaques and tangles leads to a shortage of what

A

acetylcholine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what leads to neuronal death and a higher rate of plaque formation

A

overactivation of glutamate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

cognitive symptoms of AD

A
memory loss
problems with language
disorientation to time and place
poor or decreased judgement
problems with learning and abstract thinking
misplacing things
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Noncognitive symptoms of AD

A

changes in mood or behavior
changes in personality
loss of initiative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

functional symptoms of AD

A

difficulty performing familiar tasks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What tests should be done to exclude other causes of dementia

A

depression screen, vitamin b 12 deficiency, thyroid function tests, CBC, and chemistry panel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

which medication classes are associated with cognitive impairment

A
anticholinergics
anticonvulsants
antipsychotics
benzodiazepines
hypnotics
opioids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

onset of probable AD

A

insidious

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

onset of possible AD

A

sudden

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

history of probable AD is

A

clear

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

history or possible AD is

A

unclear

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

possible AD when presence of what

A

concomitant cerebrovascular disease
features of dementia with Lewy bodies other than demetia itself
Another neurologic disease or nonneurological medical comorbidity
use of medication that could have substantial effect of cognition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

MMSE tests what areas

A
orientation
short term memory 
language
attention
praxis (performance of an action)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Mild AD MMSE score

A

18-26

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Moderate AD MMSE score

A

10-17

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Severe AD MMSE score

A

0-9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Mild AD definition

A

difficulty remembering recent events; decreased ability to manage finances, prepare food; may get lost while driving; begins to withdraw from difficult tasks and gives up hobbies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Moderate AD definition

A

requires assistance with ADL; disoriented with regards to time; recall of recent events is severely impaired; forgets details of past life and names of family/friends; function fluctuates from day-to-day; loses ability to drive safely; agitation, paranoia, and delusions are common

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Severe AD defintion

A

loses ability to speak, walk, and feed self; incontinent bowel and bladder, requires 24/7 care

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

primary goal of therapy for AD

A

treat cognitive symptoms and maintain function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

secondary goal of therapy for AD

A

treat psychiatric and behavioral symptoms that occur as a result of AD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

cholinesterase inhibitors used in AD

A

donepezil
rivastigmine
galantamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

NMDA receptor antagonist

A

memantine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
donepezil brand name
aricept
26
rivastigamine brand name
exelon
27
galantamine brand name
razadyne
28
memantine brand name
namenda
29
Treat mild-moderate AD with what medication/s
cholinesterase inhibitor
30
treat moderate to severe AD with what medication/s
memantine +/- cholinesterase inhibitor
31
when to monitor AD for safety of medications
2-4 weeks
32
When to monitor AD for effectiveness
3-6 months then Q6months
33
When is a cholinesterase inhibitor not working
greater than 2-4 point decline in MMSE per year
34
Initial dose of donepezil
5 mg QD
35
maintenance dose of donepezil
5-23 mg QD
36
Time between dose adjustment for donepezil
5-10 mg = 4-6 weeks | 10-23 mg = 12 weeks
37
therapeutic effect of cholinesterase inhibitors
slows cognitive decline by enhancing cholinergic activity
38
common AEs of cholinesterase inhibitors
nausea, vomiting, diarrhea
39
dose related AEs of cholinesterase inhibitors
``` urinary incontinence dizziness headache syncope bradycardia muscle weakness salivation sweating ```
40
cholinesterase inhibitors are for what stages of AD
mild-moderate | donepezil also severe
41
what medications should be avoided with cholinesterase inhibitors
anticholinergics
42
memantine initial dose
5 mg QD or 7 mg QD (ER capsule)
43
memantine maintenance dose
10 mg BID or 28 mg QD (ER capsule)
44
time between memantine dose adjustments
1 week
45
dose adjustments for renal impairment for memantine
CrCl < 30 - 10 mg or 14 mg QD
46
therapeutic effects of NMDA antagonist
inhibits overstimulation of glutamate
47
AEs of NMDA antagonists
``` constipation confusion dizziness headache hallucinations coughing hypertension ```
48
NMDA antagonists used for what stages of AD
moderate-severe
49
Rivastigamine initial dose
1.5 mg BID or 4.6mg/24 hour patch
50
Rivastigamine maintenance dose
3-6 mg BID or 9.5 mg/24 hour patch
51
time between dose adjustments for rivastigamine patch
4 weeks
52
time between dose adjustments for rivastigamine oral
2 weeks
53
galantamine initial dose
4 mg BID or 8 mg QD ER
54
galantamine maintenance dose
8-12 mg BID or 16-24 mg QD ER
55
time between dose adjustments for galantamine
4 weeks
56
dose adjustments for galantamine
Max 16 mg for moderate hepatic or renal funciton. DO not use in severe hepatic or renal dysfunction
57
possible underlying causes of behavioral symptoms in AD
``` pain constipation hunger/dehydration depression fear anxiety loss of sleep UTI AEs of meds ```
58
What antipsychotics used in AD and doses
olanzapine 5-10 mg Quetiapine 100-300 mg risperidone 0.75-2 mg
59
Antipsychotics treat what behavioral AD syptoms
``` hallucinations delusions suspiciousness disruptive behaviors aggitation aggression ```
60
antidepressants treat what behavioral AD symptoms
``` poor appetite insomnia hopelessness withdrawal suicidal thoughts agitation anxiety ```
61
Which antidepressants are used in AD and doses
citalopram 10-20 mg escitalopram 20-40 mg sertraline 75-100 mg
62
AEs of donepezil
``` insomnia nausea diarrhea accident infection ```
63
AEs of rivastigmine
``` dizziness weight loss headache agitation falling N/V anorexia abdominal pain tremor local reaction to patch ```
64
AEs of galantamine
Nausea vomitting diarrhea